Home >> Research Area >>Natural Products>>Steroids>> Sodium taurochenodeoxycholate

Sodium taurochenodeoxycholate

CAS# 6009-98-9

Sodium taurochenodeoxycholate

Catalog No. BCN8152----Order now to get a substantial discount!

Product Name & Size Price Stock
Sodium taurochenodeoxycholate: 5mg Please Inquire In Stock
Sodium taurochenodeoxycholate: 10mg Please Inquire In Stock
Sodium taurochenodeoxycholate: 20mg Please Inquire Please Inquire
Sodium taurochenodeoxycholate: 50mg Please Inquire Please Inquire
Sodium taurochenodeoxycholate: 100mg Please Inquire Please Inquire
Sodium taurochenodeoxycholate: 200mg Please Inquire Please Inquire
Sodium taurochenodeoxycholate: 500mg Please Inquire Please Inquire
Sodium taurochenodeoxycholate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Sodium taurochenodeoxycholate

Number of papers citing our products

Chemical structure

Sodium taurochenodeoxycholate

3D structure

Chemical Properties of Sodium taurochenodeoxycholate

Cas No. 6009-98-9 SDF Download SDF
PubChem ID 23664008 Appearance Powder
Formula C26H44NNaO6S M.Wt 521.68
Type of Compound Steroids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name sodium;2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate
SMILES CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C.[Na+]
Standard InChIKey IYPNVUSIMGAJFC-HLEJRKHJSA-M
Standard InChI InChI=1S/C26H45NO6S.Na/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29;/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);/q;+1/p-1/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-;/m1./s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Sodium taurochenodeoxycholate

The bear biliary.

Biological Activity of Sodium taurochenodeoxycholate

Description1. Sodium taurochenodeoxycholate can increase glucose-induced insulin secretion and stimulate the electrical activity of β-cells and enhance cytosolic Ca(2+) concentration ([Ca(2+)](c)).
TargetsATPase | Potassium Channel | Calcium Channel

Sodium taurochenodeoxycholate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Sodium taurochenodeoxycholate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Sodium taurochenodeoxycholate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9169 mL 9.5844 mL 19.1688 mL 38.3377 mL 47.9221 mL
5 mM 0.3834 mL 1.9169 mL 3.8338 mL 7.6675 mL 9.5844 mL
10 mM 0.1917 mL 0.9584 mL 1.9169 mL 3.8338 mL 4.7922 mL
50 mM 0.0383 mL 0.1917 mL 0.3834 mL 0.7668 mL 0.9584 mL
100 mM 0.0192 mL 0.0958 mL 0.1917 mL 0.3834 mL 0.4792 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Sodium taurochenodeoxycholate

Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition.[Pubmed:22492528]

Diabetes. 2012 Jun;61(6):1479-89.

Type 2 diabetes mellitus is associated with alterations in bile acid (BA) signaling. The aim of our study was to test whether pancreatic beta-cells contribute to BA-dependent regulation of glucose homeostasis. Experiments were performed with islets from wild-type, farnesoid X receptor (FXR) knockout (KO), and beta-cell ATP-dependent K(+) (K(ATP)) channel gene SUR1 (ABCC8) KO mice, respectively. Sodium taurochenodeoxycholate (TCDC) increased glucose-induced insulin secretion. This effect was mimicked by the FXR agonist GW4064 and suppressed by the FXR antagonist guggulsterone. TCDC and GW4064 stimulated the electrical activity of beta-cells and enhanced cytosolic Ca(2+) concentration ([Ca(2+)](c)). These effects were blunted by guggulsterone. Sodium ursodeoxycholate, which has a much lower affinity to FXR than TCDC, had no effect on [Ca(2+)](c) and insulin secretion. FXR activation by TCDC is suggested to inhibit K(ATP) current. The decline in K(ATP) channel activity by TCDC was only observed in beta-cells with intact metabolism and was reversed by guggulsterone. TCDC did not alter insulin secretion in islets of SUR1-KO or FXR-KO mice. TCDC did not change islet cell apoptosis. This is the first study showing an acute action of BA on beta-cell function. The effect is mediated by FXR by nongenomic elements, suggesting a novel link between FXR activation and K(ATP) channel inhibition.

Keywords:

Sodium taurochenodeoxycholate,6009-98-9,Natural Products, buy Sodium taurochenodeoxycholate , Sodium taurochenodeoxycholate supplier , purchase Sodium taurochenodeoxycholate , Sodium taurochenodeoxycholate cost , Sodium taurochenodeoxycholate manufacturer , order Sodium taurochenodeoxycholate , high purity Sodium taurochenodeoxycholate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: